research-article

You have full text access to this OnlineOpen article

Concise Review: Roles of Polycomb Group Proteins in Development and Disease: A Stem Cell Perspective

Vinagolu K. Rajasekhar M.Sc., M.Phil., Ph.D.^1,*,
Martin Begemann²

Article first published online: 28 JUN 2007

DOI: 10.1634/stemcells.2006-0608

Issue

STEM CELLS

Volume 25, Issue 10, pages 2498–2510, October 2007

Additional Information

How to Cite

Rajasekhar, V. K. and Begemann, M. (2007), Concise Review: Roles of Polycomb Group Proteins in Development and Disease: A Stem Cell Perspective. STEM CELLS, 25: 2498–2510. doi: 10.1634/stemcells.2006-0608

Author Information

¹
Memorial Sloan-Kettering Cancer Center, New York, New York, USA
²
Max Planck Institute for Experimental Medicine, Goettingen, Germany

Email: Vinagolu K. Rajasekhar M.Sc., M.Phil., Ph.D. (vinagolr@mskcc.org)

^*Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Rockefeller Research Laboratories, Room #945, New York, New York 10021, USA. Telephone: 646-247-0060; Fax: 212-717-3627

Publication History

Issue published online: 2 JAN 2009
Article first published online: 28 JUN 2007
Manuscript Accepted: 14 JUN 2007
Manuscript Received: 28 SEP 2006

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (540K)

References

1
Waddington CH. The epigenotype. Endeavour 1942; 1:18–20.
2
Grimaud C, Negre N, Cavalli G. From genetics to epigenetics: The tale of Polycomb group and trithorax group genes. Chromosome Res 2006; 14:363–375.
3
Richards EJ. Inherited epigenetic variation—revisiting soft inheritance. Nat Rev Genet 2006; 7:395–401.
4
Orlando V. Polycomb, epigenomes, and control of cell identity. Cell 2003; 112:599–606.
5
Ptashne M. On the use of the word ‘epigenetic.’. Curr Biol 2007; 17:R233–236.
6
Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007; 128:669–681.
7
Gottschling DE. Summary: Epigenetics—from phenomenon to field. Cold Spring Harb Symp Quant Biol 2004; 69:507–519.
- CrossRef,
- PubMed,
- CAS
8
Ptashne M, Johnson AD, Pabo CO. A genetic switch in a bacterial virus. Sci Am 1982; 247:134–140.
- CrossRef
9
Jaenisch R, Bird A. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33:245–254.
10
Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004; 118:409–418.
11
Morgan HD, Santos F, Green K et al. Epigenetic reprogramming in mammals. Hum Mol Genet 2005; 14Spec No 1:R47–58.
12
Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6:846–856.
13
Lotem J, Sachs L. Epigenetics and the plasticity of differentiation in normal and cancer stem cells. Oncogene 2006; 25:7663–7672.
14
Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7:21–33.
15
Ting AH, McGarvey KM, Baylin SB. The cancer epigenome—components and functional correlates. Genes Dev 2006; 20:3215–3231.
16
Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683–692.
17
Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell 2007; 128:747–762.
18
Spivakov M, Fisher AG. Epigenetic signatures of stem-cell identity. Nat Rev Genet 2007; 8:263–271.
19
Misteli T. Beyond the sequence: Cellular organization of genome function. Cell 2007; 128:787–800.
20
Barrera LO, Ren B. The transcriptional regulatory code of eukaryotic cells - insights from genome-wide analysis of chromatin organization and transcription factor binding. Curr Opin Cell Biol 2006; 18:291–298.
21
Quina AS, Buschbeck M, Di Croce L. Chromatin structure and epigenetics. Biochem Pharmacol 2006; 72:1563–1569.
22
Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002; 108:475–487.
23
Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128:707–719.
24
Rea S, Eisenhaber F, O'Carroll D et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406:593–599.
25
Gan Q, Yoshida T, McDonald OG et al. Concise review: Epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 2007; 25:2–9.
Direct Link:
26
Klose RJ, Bird AP. Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci 2006; 31:89–97.
27
Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002; 99:3740–3745.
28
Ramsahoye BH, Biniszkiewicz D, Lyko F et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci U S A 2000; 97:5237–5242.
29
Simonsson S, Gurdon J. DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Biol 2004; 6:984–990.
30
Schaefer CB, Ooi SK, Bestor TH et al. Epigenetic decisions in mammalian germ cells. Science 2007; 316:398–399.
31
Lagarkova MA, Volchkov PY, Lyakisheva AV et al. Diverse epigenetic profile of novel human embryonic stem cell lines. Cell Cycle 2006; 5:416–420.
32
Gilbert N, Thomson I, Boyle S et al. DNA methylation affects nuclear organization, histone modifications, and linker histone binding but not chromatin compaction. J Cell Biol 2007; 177:401–411.
33
Jones PL, Veenstra GJ, Wade PA et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998; 19:187–191.
34
Nan X, Ng HH, Johnson CA et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998; 393:386–389.
35
Ringrose L. Polycomb, trithorax and the decision to differentiate. Bioessays 2006; 28:330–334.
Direct Link:
36
Schwartz YB, Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 2007; 8:9–22.
37
Schuettengruber B, Chourrout D, Vervoort M et al. Genome regulation by polycomb and trithorax proteins. Cell 2007; 128:735–745.
38
Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 2004; 38:413–443.
39
Barski A, Cuddapah S, Cui K et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823–837.
40
Ringrose L, Paro R. Polycomb/Trithorax response elements and epigenetic memory of cell identity. Development 2007; 134:223–232.
41
Bernstein BE, Kamal M, Lindblad-Toh K et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120:169–181.
42
Kim TH, Barrera LO, Zheng M et al. A high-resolution map of active promoters in the human genome. Nature 2005; 436:876–880.
43
Roh TY, Cuddapah S, Cui K et al. The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci U S A 2006; 103:15782–15787.
44
Martinez AM, Cavalli G. The role of polycomb group proteins in cell cycle regulation during development. Cell Cycle 2006; 5:1189–1197.
45
Su IH, Dobenecker MW, Dickinson E et al. Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 2005; 121:425–436.
46
Guney I, Sedivy JM. Cellular senescence, epigenetic switches and c-Myc. Cell Cycle 2006; 5:2319–2323.
47
Heard E. Delving into the diversity of facultative heterochromatin: The epigenetics of the inactive X chromosome. Curr Opin Genet Dev 2005; 15:482–489.
48
Mager J, Montgomery ND, de Villena FP et al. Genome imprinting regulated by the mouse Polycomb group protein Eed. Nat Genet 2003; 33:502–507.
49
Hosokawa H, Kimura MY, Shinnakasu R et al. Regulation of Th2 cell development by Polycomb group gene bmi-1 through the stabilization of GATA3. J Immunol 2006; 177:7656–7664.
50
Oguro H, Iwama A, Morita Y et al. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J Exp Med 2006; 203:2247–2253.
51
Almeida R, Allshire RC. RNA silencing and genome regulation. Trends Cell Biol 2005; 15:251–258.
52
Grimaud C, Bantignies F, Pal-Bhadra M et al. RNAi components are required for nuclear clustering of Polycomb group response elements. Cell 2006; 124:957–971.
53
Lin H. piRNAs in the germ line. Science 2007; 316:397.
54
Bernstein E, Duncan EM, Masui O et al. Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Mol Cell Biol 2006; 26:2560–2569.
55
Zaratiegui M, Irvine DV, Martienssen RA. Noncoding RNAs and gene silencing. Cell 2007; 128:763–776.
56
Yang PK, Kuroda MI. Noncoding RNAs and intranuclear positioning in monoallelic gene expression. Cell 2007; 128:777–786.
57
Bernstein E, Allis CD. RNA meets chromatin. Genes Dev 2005; 19:1635–1655.
58
Kim DH, Villeneuve LM, Morris KV et al. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 2006; 13:793–797.
59
Cheng LC, Tavazoie M, Doetsch F. Stem cells: From epigenetics to microRNAs. Neuron 2005; 46:363–367.
60
Lee TI, Jenner RG, Boyer LA et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006; 125:301–313.
61
Saito Y, Jones PA. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 2006; 5:2220–2222.
62
Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 1978; 276:565–570.
63
Struhl G. A gene product required for correct initiation of segmental determination in Drosophila. Nature 1981; 293:36–41.
64
Levine SS, King IF, Kingston RE. Division of labor in polycomb group repression. Trends Biochem Sci 2004; 29:478–485.
65
Groth A, Rocha W, Verreault A et al. Chromatin challenges during DNA replication and repair. Cell 2007; 128:721–733.
66
Pasini D, Bracken AP, Jensen MR et al. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 2004; 23:4061–4071.
67
O'Carroll D, Erhardt S, Pagani M et al. The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 2001; 21:4330–4336.
68
Faust C, Schumacher A, Holdener B et al. The eed mutation disrupts anterior mesoderm production in mice. Development 1995; 121:273–285.
69
Tolhuis B, Muijrers I, de Wit E et al. Genome-wide profiling of PRC1 and PRC2 Polycomb chromatin binding in Drosophila melanogaster. Nat Genet 2006; 38:694–699.
70
Schwartz YB, Kahn TG, Nix DA et al. Genome-wide analysis of Polycomb targets in Drosophila melanogaster. Nat Genet 2006; 38:700–705.
71
Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 2004; 15:57–67.
72
Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 2005; 20:845–854.
73
Kuzmichev A, Jenuwein T, Tempst P et al. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 2004; 14:183–193.
74
Boyer LA, Mathur D, Jaenisch R. Molecular control of pluripotency. Curr Opin Genet Dev 2006; 16:455–462.
75
Voncken JW, Roelen BA, Roefs M et al. Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. Proc Natl Acad Sci U S A 2003; 100:2468–2473.
76
Isono K, Fujimura Y, Shinga J et al. Mammalian polyhomeotic homologues Phc2 and Phc1 act in synergy to mediate polycomb repression of Hox genes. Mol Cell Biol 2005; 25:6694–6706.
77
Jorgensen HF, Giadrossi S, Casanova M et al. Stem cells primed for action: Polycomb repressive complexes restrain the expression of lineage-specific regulators in embryonic stem cells. Cell Cycle 2006; 5:1411–1414.
78
Bracken AP, Dietrich N, Pasini D et al. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20:1123–1136.
79
de la Cruz CC, Kirmizis A, Simon MD et al. The polycomb group protein SUZ12 regulates histone H3 lysine 9 methylation and HP1alpha distribution. Chromosome Res 2007; 15:299–314.
- PubMed,
- CAS
80
de Wit E, Greil F, van Steensel B. High-resolution mapping reveals links of HP1 with active and inactive chromatin components. PLoS Genet 2007; 3:e38.
81
Chen X, Hiller M, Sancak Y et al. Tissue-specific TAFs counteract Polycomb to turn on terminal differentiation. Science 2005; 310:869–872.
82
Chopra VS, Mishra RK. To SIR with Polycomb: linking silencing mechanisms. Bioessays 2005; 27:119–121.
Direct Link:
83
Lund AH, van Lohuizen M. Epigenetics and cancer. Genes Dev 2004; 18:2315–2335.
84
Lund AH, van Lohuizen M. Polycomb complexes and silencing mechanisms. Curr Opin Cell Biol 2004; 16:239–246.
85
Kuzmichev A, Margueron R, Vaquero A et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci U S A 2005; 102:1859–1864.
86
Varambally S, Dhanasekaran SM, Zhou M et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419:624–629.
87
Gil J, Bernard D, Peters G. Role of polycomb group proteins in stem cell self-renewal and cancer. DNA Cell Biol 2005; 24:117–125.
88
Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693–705.
89
Strutt H, Paro R. The polycomb group protein complex of Drosophila melanogaster has different compositions at different target genes. Mol Cell Biol 1997; 17:6773–6783.
90
Su IH, Tarakhovsky A. Lysine methylation and ‘signaling memory’. Curr Opin Immunol 2006; 18:152–157.
91
Voncken JW, Schweizer D, Aagaard L et al. Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status. J Cell Sci 1999; 112:4627–4639.
92
Vire E, Brenner C, Deplus R et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439:871–874.
93
Taghavi P, van Lohuizen M. Developmental biology: Two paths to silence merge. Nature 2006; 439:794–795.
94
Hernandez-Munoz I, Taghavi P, Kuijl C et al. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1. Mol Cell Biol 2005; 25:11047–11058.
95
Torres-Padilla ME, Parfitt DE, Kouzarides T et al. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 2007; 445:214–218.
96
Rajasekhar VK, Vemuri MC. Molecular insights into the function, fate, and prospects of stem cells. Stem Cells 2005; 23:1212–1220.
Direct Link:
97
Rando TA. Stem cells, ageing and the quest for immortality. Nature 2006; 441:1080–1086.
98
Kerr CL, Shamblott MJ, Gearhart JD. Pluripotent stem cells from germ cells. Methods Enzymol 2006; 419:400–426.
99
Iwama A, Oguro H, Negishi M et al. Epigenetic regulation of hematopoietic stem cell self-renewal by polycomb group genes. Int J Hematol 2005; 81:294–300.
100
de la Cruz CC, Fang J, Plath K et al. Developmental regulation of Suz 12 localization. Chromosoma 2005; 114:183–192.
101
Pasini D, Bracken AP, Hansen JB et al. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol 2007; 27:3769–3779.
102
Erhardt S, Su IH, Schneider R et al. Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development. Development 2003; 130:4235–4248.
103
Meshorer E, Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol 2006; 7:540–546.
104
Boyer LA, Plath K, Zeitlinger J et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006; 441:349–353.
105
Azuara V, Perry P, Sauer S et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006; 8:532–538.
106
Tada T. Toti-/pluripotential stem cells and epigenetic modifications. Neurodegener Dis 2006; 3:32–37.
107
Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122:947–956.
108
Loh YH, Wu Q, Chew JL et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006; 38:431–440.
109
Squazzo SL, O'Geen H, Komashko VM et al. Suz12 binds to silenced regions of the genome in a cell-type-specific manner. Genome Res 2006; 16:890–900.
110
de Haan G. Epigenetic control of hematopoietic stem cell aging, the case of Ezh2. Ann N Y Acad Sci 2007; [Epub ahead of print].
Direct Link:
111
Yeoh JS, de Haan G. Fibroblast growth factors as regulators of stem cell self-renewal and aging. Mech Ageing Dev 2007; 128:17–24.
112
Kamminga LM, de Haan G. Cellular memory and hematopoietic stem cell aging. Stem Cells 2006; 24:1143–1149.
Direct Link:
113
Kamminga LM, Bystrykh LV, de Boer A et al. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood 2006; 107:2170–2179.
114
Iwama A, Oguro H, Negishi M et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 2004; 21:843–851.
115
Lessard J, Schumacher A, Thorsteinsdottir U et al. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes Dev 1999; 13:2691–2703.
116
Leung C, Lingbeek M, Shakhova O et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004; 428:337–341.
117
Molofsky AV, He S, Bydon M et al. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 2005; 19:1432–1437.
118
Molofsky AV, Pardal R, Iwashita T et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425:962–967.
119
Caretti G, Di Padova M, Micales B et al. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004; 18:2627–2638.
120
Bibikova M, Chudin E, Wu B et al. Human embryonic stem cells have a unique epigenetic signature. Genome Res 2006; 16:1075–1083.
121
Zvetkova I, Apedaile A, Ramsahoye B et al. Global hypomethylation of the genome in XX embryonic stem cells. Nat Genet 2005; 37:1274–1279.
122
Sado T, Okano M, Li E et al. De novo DNA methylation is dispensable for the initiation and propagation of X chromosome inactivation. Development 2004; 131:975–982.
123
Lehnertz B, Ueda Y, Derijck AA et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003; 13:1192–1200.
124
Mermoud JE, Popova B, Peters AH et al. Histone H3 lysine 9 methylation occurs rapidly at the onset of random X chromosome inactivation. Curr Biol 2002; 12:247–251.
125
Maitra A, Arking DE, Shivapurkar N et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005; 37:1099–1103.
126
Tada M, Tada T, Lefebvre L et al. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J 1997; 16:6510–6520.
127
Wang J, Mager J, Chen Y et al. Imprinted X inactivation maintained by a mouse Polycomb group gene. Nat Genet 2001; 28:371–375.
128
Takagi N, Sasaki M. Preferential inactivation of the paternally derived X chromosome in the extraembryonic membranes of the mouse. Nature 1975; 256:640–642.
129
Muyrers-Chen I, Hernandez-Munoz I, Lund AH et al. Emerging roles of Polycomb silencing in X-inactivation and stem cell maintenance. Cold Spring Harb Symp Quant Biol 2004; 69:319–326.
130
Kalantry S, Magnuson T. The Polycomb group protein EED is dispensable for the initiation of random X-chromosome inactivation. PLoS Genet 2006; 2:e66.
131
Kalantry S, Mills KC, Yee D et al. The Polycomb group protein Eed protects the inactive X-chromosome from differentiation-induced reactivation. Nat Cell Biol 2006; 8:195–202.
132
Mak W, Nesterova TB, de Napoles M et al. Reactivation of the paternal X chromosome in early mouse embryos. Science 2004; 303:666–669.
133
de Napoles M, Mermoud JE, Wakao R et al. Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev Cell 2004; 7:663–676.
134
McLaren A. Primordial germ cells in the mouse. Dev Biol 2003; 262:1–15.
135
Surani MA, Ancelin K, Hajkova P et al. Mechanism of mouse germ cell specification: A genetic program regulating epigenetic reprogramming. Cold Spring Harb Symp Quant Biol 2004; 69:1–9.
136
McLaren A, Monk M. X-chromosome activity in the germ cells of sex-reversed mouse embryos. J Reprod Fertil 1981; 63:533–537.
137
Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125:315–326.
138
Negre N, Hennetin J, Sun LV et al. Chromosomal distribution of PcG proteins during Drosophila development. PLoS Biol 2006; 4:e170.
139
Dejardin J, Rappailles A, Cuvier O et al. Recruitment of Drosophila Polycomb group proteins to chromatin by DSP1. Nature 2005; 434:533–538.
140
Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: A repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002; 110:339–348.
141
Kimura H, Tada M, Nakatsuji N et al. Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol Cell Biol 2004; 24:5710–5720.
142
Mellor J. Dynamic nucleosomes and gene transcription. Trends Genet 2006; 22:320–329.
143
Orlando V, Jane EP, Chinwalla V et al. Binding of trithorax and Polycomb proteins to the bithorax complex: Dynamic changes during early Drosophila embryogenesis. EMBO J 1998; 17:5141–5150.
144
Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006; 441:1068–1074.
145
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57–70.
146
Enver T, Soneji S, Joshi C et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 2005; 14:3129–3140.
147
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415–428.
148
Frigola J, Song J, Stirzaker C et al. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006; 38:540–549.
149
Cadieux B, Ching TT, Vandenberg SR et al. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 2006; 66:8469–8476.
150
Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8:286–298.
151
Fraga MF, Ballestar E, Villar-Garea A et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005; 37:391–400.
152
Seligson DB, Horvath S, Shi T et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435:1262–1266.
153
Widschwendter M, Fiegl H, Egle D et al. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39:157–158.
154
Pasini D, Bracken AP, Helin K. Polycomb group proteins in cell cycle progression and cancer. Cell Cycle 2004; 3:396–400.
155
Raaphorst FM. Of mice, flies, and man: The emerging role of polycomb-group genes in human malignant lymphomas. Int J Hematol 2005; 81:281–287.
156
Bracken AP, Pasini D, Capra M et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 2003; 22:5323–5335.
157
Tan J, Yang X, Zhuang L et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev 2007; 21:1050–1063.
158
Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3:895–902.
159
Parrish JZ, Emoto K, Jan LY et al. Polycomb genes interact with the tumor suppressor genes hippo and warts in the maintenance of Drosophila sensory neuron dendrites. Genes Dev 2007; 21:956–972.
160
Pardal R, Molofsky AV, He S et al. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb Symp Quant Biol 2005; 70:177–185.
161
Sharpless NE, DePinho RA. Cancer: Crime and punishment. Nature 2005; 436:636–637.
162
Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006; 4:221–233.
163
Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860–867.
164
Baylin SB, Ohm JE. Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107–116.
165
Reya T, Morrison SJ, Clarke MF et al. Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105–111.
166
Wicha MS, Liu S, Dontu G. Cancer stem cells: An old idea—a paradigm shift. Cancer Res 2006; 66:1883–1890.
167
Clarke MF, Fuller M. Stem cells and cancer: Two faces of eve. Cell 2006; 124:1111–1115.
168
Ohm JE, McGarvey KM, Yu X et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39:237–242.
169
Dahiya A, Wong S, Gonzalo S et al. Linking the Rb and polycomb pathways. Mol Cell 2001; 8:557–569.
170
Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene 2001; 20:8085–8091.
171
Ezeh UI, Turek PJ, Reijo RA et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005; 104:2255–2265.
Direct Link:
172
Gidekel S, Pizov G, Bergman Y et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003; 4:361–370.
173
Hochedlinger K, Blelloch R, Brennan C et al. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev 2004; 18:1875–1885.
174
Hochedlinger K, Yamada Y, Beard C et al. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005; 121:465–477.
175
Margueron R, Trojer P, Reinberg D. The key to development: Interpreting the histone code? Curr Opin Genet Dev 2005; 15:163–176.
176
Schlesinger Y, Straussman R, Keshet I et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39:232–236.
177
Ohm JE, Baylin SB. Stem cell chromatin patterns: An instructive mechanism for DNA hypermethylation? Cell Cycle 2007; 6:1040–1043.
178
Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2007; 96:R26–30.
- PubMed
179
Jacobs JJ, Kieboom K, Marino S et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999; 397:164–168.
180
Molofsky AV, Slutsky SG, Joseph NM et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 2006; 443:448–452.
181
Bruggeman SW, Valk-Lingbeek ME, van der Stoop PP et al. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev 2005; 19:1438–1443.
182
Kotake Y, Cao R, Viatour P et al. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 2007; 21:49–54.
183
Bracken AP, Kleine-Kohlbrecher D, Dietrich N et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007; 21:525–530.
184
Janzen V, Forkert R, Fleming HE et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006; 443:421–426.
185
Krishnamurthy J, Ramsey MR, Ligon KL et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006; 443:453–457.
186
Ding L, Erdmann C, Chinnaiyan AM et al. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Res 2006; 66:4095–4099.
187
Fiskus W, Pranpat M, Balasis M et al. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Mol Cancer Ther 2006; 5:3096–3104.
188
McGarvey KM, Fahrner JA, Greene E et al. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 2006; 66:3541–3549.
189
Baglole CJ, Ray DM, Bernstein SH et al. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest 2006; 35:297–325.
190
Moore KA, Lemischka IR. Stem cells and their niches. Science 2006; 311:1880–1885.
191
Bissell MJ, Labarge MA. Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment? Cancer Cell 2005; 7:17–23.
192
Li L, Neaves WB. Normal stem cells and cancer stem cells: The niche matters. Cancer Res 2006; 66:4553–4557.
193
Hu M, Yao J, Cai L et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005; 37:899–905.
194
Pritsker M, Ford NR, Jenq HT et al. Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc Natl Acad Sci U S A 2006; 103:6946–6951.
195
Cavalli G. Chromatin and epigenetics in development: Blending cellular memory with cell fate plasticity. Development 2006; 133:2089–2094.
196
Orkin SH. Chipping away at the embryonic stem cell network. Cell 2005; 122:828–830.
197
Lee H, Habas R, Abate-Shen C. MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis. Science 2004; 304:1675–1678.
198
Lee H, Quinn JC, Prasanth KV et al. PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev 2006; 20:784–794.
199
Chagraoui J, Niessen SL, Lessard J et al. E4F1: A novel candidate factor for mediating BMI1 function in primitive hematopoietic cells. Genes Dev 2006; 20:2110–2120.
200
Mohd-Sarip A, van der Knaap JA, Wyman C et al. Architecture of a polycomb nucleoprotein complex. Mol Cell 2006; 24:91–100.
201
Rajasekhar VK. Analytical methods for cancer stem cells. In: VemuriMC, ed. Stem Cell Assays. Totowa, NJ: Humana Press, 2007;83–95.
- CrossRef
202
Wegel E, Shaw P. Gene activation and deactivation related changes in the three-dimensional structure of chromatin. Chromosoma 2005; 114:331–337.
203
Beck HC, Nielsen EC, Matthiesen R et al. Quantitative proteomic analysis of post-translational modifications of human histones. Mol Cell Proteomics 2006; 5:1314–1325.
204
Heintzman ND, Stuart RK, Hon G et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39:311–318.
205
O'Neill LP, VerMilyea MD, Turner BM. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nat Genet 2006; 38:835–841.
206
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663–676.
207
Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; [Epub ahead of print].
208
Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; [Epub ahead of print].
209
Maherali N, Sridharan R, Xie W et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and wide spread tissue contribution. Cell Stem Cell 2007; 1:55–70.
210
Bantignies F, Cavalli G. Cellular memory and dynamic regulation of polycomb group proteins. Curr Opin Cell Biol 2006; 18:275–283.
211
Berezovska OP, Glinskii AB, Yang Z et al. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle 2006; 5:1886–1901.
212
Sanchez-Beato M, Sanchez E, Gonzalez-Carrero J et al. Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays. Mod Pathol 2006; 19:684–694.
213
Bea S, Tort F, Pinyol M et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001; 61:2409–2412.
214
Saramaki OR, Tammela TL, Martikainen PM et al. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer. Genes Chromosomes Cancer 2006; 45:639–645.
Direct Link:
215
Tokimasa S, Ohta H, Sawada A et al. Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage. Exp Hematol 2001; 29:93–103.
216
van Kemenade FJ, Raaphorst FM, Blokzijl T et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001; 97:3896–3901.
217
Arisan S, Buyuktuncer ED, Palavan-Unsal N et al. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma. Urol Int 2005; 75:252–257.
218
Weikert S, Christoph F, Kollermann J et al. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med 2005; 16:349–353.
219
Raman JD, Mongan NP, Tickoo SK et al. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res 2005; 11:8570–8576.
220
Collett K, Eide GE, Arnes J et al. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. Clin Cancer Res 2006; 12:1168–1174.
221
Bachmann IM, Halvorsen OJ, Collett K et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 2006; 24:268–273.
222
Kleer CG, Cao Q, Varambally S et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003; 100:11606–11611.
223
Mimori K, Ogawa K, Okamoto M et al. Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases. Eur J Surg Oncol 2005; 31:376–380.
224
Raaphorst FM, van Kemenade FJ, Blokzijl T et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 2000; 157:709–715.
225
Sudo T, Utsunomiya T, Mimori K et al. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer 2005; 92:1754–1758.
226
Visser HP, Gunster MJ, Kluin-Nelemans HC et al. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol 2001; 112:950–958.
Direct Link:
227
van Leenders GJ, Dukers D, Hessels D et al. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur Urol 2007; 52:455–463.
228
Beke L, Nuytten M, Van Eynde A et al. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2. Oncogene 2007; 26:4590–4595.
229
Chen H, Tu SW, Hsieh JT. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. J Biol Chem 2005; 280:22437–22444.
230
Matsukawa Y, Semba S, Kato H et al. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci 2006; 97:484–491.
Direct Link:
231
Kirmizis A, Bartley SM, Farnham PJ. Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol Cancer Ther 2003; 2:113–121.
232
Breuer RH, Snijders PJ, Smit EF et al. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia 2004; 6:736–743.
233
Tateishi K, Ohta M, Kanai F et al. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res 2006; 12:6960–6966.
234
Prince ME, Sivanandan R, Kaczorowski A et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104:973–978.
235
Dukers DF, van Galen JC, Giroth C et al. Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. Am J Pathol 2004; 164:873–881.
236
Sawa M, Yamamoto K, Yokozawa T et al. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol 2005; 82:42–47.
237
Song LB, Zeng MS, Liao WT et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006; 66:6225–6232.
238
Nowak K, Kerl K, Fehr D et al. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res 2006; 34:1745–1754.
239
Vonlanthen S, Heighway J, Altermatt HJ et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001; 84:1372–1376.
240
Breuer RH, Snijders PJ, Sutedja GT et al. Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions. Lung Cancer 2005; 48:299–306.
241
Kang MK, Kim RH, Kim SJ et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 2007; 96:126–133.
242
Gordon S, Akopyan G, Garban H et al. Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology. Oncogene 2006; 25:1125–1142.
243
Wang S, He F, Xiong W et al. Polycomblike-2-deficient mice exhibit normal left-right asymmetry. Dev Dyn 2007; 236:853–861.
Direct Link:

View Full Article with Supporting Information (HTML) Get PDF (540K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Concise Review: Roles of Polycomb Group Proteins in Development and Disease: A Stem Cell Perspective

STEM CELLS

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Concise Review: Roles of Polycomb Group Proteins in Development and Disease: A Stem Cell Perspective

STEM CELLS

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this